Izrael - héber - Ministry of Health

teva israel ltd - dasatinib as monohydrate - טבליות מצופות פילם - dasatinib as monohydrate 100 mg - dasatinib

Izrael - héber - Ministry of Health

teva israel ltd - dasatinib as monohydrate - טבליות מצופות פילם - dasatinib as monohydrate 20 mg - dasatinib

Izrael - héber - Ministry of Health

teva israel ltd - dasatinib as monohydrate - טבליות מצופות פילם - dasatinib as monohydrate 50 mg - dasatinib

Izrael - héber - Ministry of Health

teva israel ltd - dasatinib as monohydrate - טבליות מצופות פילם - dasatinib as monohydrate 70 mg - dasatinib

Izrael - héber - Ministry of Health

tzamal bio-pharma ltd - busulfan - תמיסה להזרקה - busulfan 60 mg / 10 ml - busulfan - busulfan - for use in combination with other chemotherapeutic agents and/or radiotherapy as a conditioning regimen prior to hematopoietic progenitor cell transplantation.

Izrael - héber - Ministry of Health

pfizer pharmaceuticals israel ltd - sunitinib as malate 37.5 mg - capsules - sunitinib - sutent is indicated for the treatment of gastrointestinal stromal tumor after disease progression on or intolerance to imatinib mesylate. sutent is indicated for the treatment of advanced renal cell carcinoma.treatment of unresectable or metastatic, well differentiated pancreatic neuroendocrine tumours (pnet) with disease progression.

Izrael - héber - Ministry of Health

novartis israel ltd - nilotinib as hydrochloride monohydrate - קפסולות - nilotinib as hydrochloride monohydrate 150 mg - nilotinib - nilotinib - treatment of adult patients with newly diagnosed philadelphia chromosome positive chronic myelogenous leukemia in chronic phase.

Izrael - héber - Ministry of Health

teva israel ltd - sunitinib as base - קפסולות - sunitinib as base 12.5 mg - sunitinib

Izrael - héber - Ministry of Health

teva israel ltd - sunitinib as base - קפסולות - sunitinib as base 25 mg - sunitinib

Izrael - héber - Ministry of Health

teva israel ltd - sunitinib as base - קפסולות - sunitinib as base 37.5 mg - sunitinib